Published date: 25 October 2019

Last edited date: 3 June 2020

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Approach to market date: 8 June 2020

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region, Scotland, Wales, Northern Ireland

Value of contract

£0

Procurement reference

CM/EMP/15/5473/662

Published date

25 October 2019

Approach to market date

8 June 2020

Contract start date

1 April 2021

Contract end date

31 March 2022

Procedure type

Restricted procedure (above threshold)

A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Please be aware that initial indications to the market was that this opportunity would be for a framework agreement. This has now changed to a requirement for a contract to be put in place.
The purpose of the procurement exercise will be intended to establish a contract for Public Health England's requirements for the stockpile of emergency medicines. This includes the provision of: atropine PFS, ciprofloxacin tablets (including 100 mg strength) ciprofloxacin suspension and ciprofloxacin injection.The duration of the contract is 1 year from April 2021.

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2021/2022 £0

Attachments

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

lynne.nichols@dhsc.gov.uk